✉ Email this page to a colleague
« Back to Dashboard
Akten is a drug marketed by Akorn and is included in one NDA. There is one patent protecting this drug.
This drug has two patent family members in two countries.
The generic ingredient in AKTEN is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.
A generic version of AKTEN was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.
Summary for AKTEN
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||125|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for AKTEN|
|What excipients (inactive ingredients) are in AKTEN?||AKTEN excipients list|
|DailyMed Link:||AKTEN at DailyMed|
Anatomical Therapeutic Chemical (ATC) Classes for AKTEN
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Akorn||AKTEN||lidocaine hydrochloride||GEL;OPHTHALMIC||022221-001||Oct 7, 2008||RX||Yes||Yes||See Plans and Pricing||See Plans and Pricing||Y||See Plans and Pricing|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
See the table below for patents covering AKTEN around the world.
|Country||Patent Number||Title||Estimated Expiration|
|European Patent Office||2043601||FORMULATION DE GEL AQUEUX ET PROCÉDÉ POUR INDUIRE UNE ANESTHÉSIE TOPIQUE (AQUEOUS GEL FORMULATION AND METHOD FOR INDUCING TOPICAL ANESTHESIA)||See Plans and Pricing|
|World Intellectual Property Organization (WIPO)||2008014036||See Plans and Pricing|
|>Country||>Patent Number||>Title||>Estimated Expiration|